Embedded type graded drug release three-dimensional rack and preparation method thereof
A three-dimensional stent and embedded technology, which is applied in the direction of stents, drug devices, and other medical devices, can solve the problems of inability to realize drug gradient loading and distribution, uneven drug distribution, and single type of stent drug loading.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] Embodiment one: see figure 1 , the embedded three-dimensional stent for graded release of drugs is composed of an inner layer blank (1) and an outer wrapping blank (2), and is characterized in that:
[0044] 1), the inner layer form (1) is a calcium phosphate form uniformly mixed with drug D1, the slurry used for the preparation of the form: the content of calcium phosphate is 10%±0.5%, the content of drug D1 is 0.0017, and the balance for distilled water;
[0045] 2), the outer wrapping form (2) is a calcium phosphate form uniformly mixed with drug D2, wherein drug D2 is a different type of drug from drug D1, and the slurry used for the preparation of the form is: the content of calcium phosphate is 20 %±0.5%, the content of drug D2 is 0.0085, and the balance is distilled water;
[0046] 3) The drug content = drug mass mg / mass g of biological experiment living sample.
[0047] The preparation process steps of this support are as follows:
[0048] ...
Embodiment 2
[0051] Embodiment two: see figure 2 , the embedded three-dimensional stent for graded drug release is composed of an inner shape (1), a middle wrapping shape (3) and an outer shape (2), and is characterized in that:
[0052] 1), the inner layer form (1) is a calcium phosphate form uniformly mixed with drug D1, the slurry used for the preparation of the form: the content of calcium phosphate is 10%±0.5%, the content of drug D1 is 0.0020, and the balance for distilled water;
[0053] 2) The middle layer shape (3) is a calcium phosphate shape uniformly mixed with drug D2. Drug D2 is a different type of drug from drug D1. The slurry used for the preparation of the shape body is: the content of calcium phosphate is 20%±0.5 %, the content of drug D2 is 0.0017, and the balance is distilled water;
[0054] 3), the outer wrapping shape (2) is a calcium phosphate shape uniformly mixed with drug D3, wherein drug D3 is a different type of drug from drug D1 and drug D2, an...
Embodiment 3
[0061] Embodiment three: This example is basically the same as Example 1. The drug D1 is deferoxamine, and the drug D2 is the small molecule compound OIC-006. The preparation process steps of this stent are as follows:
[0062] First, use a small negative type ( image 3 ) Forming the inner layer blank SD1 of the drug-loaded stent: First, uniformly mix the hypoxic mimetic compound deferoxamine (drug D1) that promotes osteogenesis and the slurry with a calcium phosphate content of 10%±0.5% to obtain the inner layer stent slurry. Next, inject the inner layer stent slurry into the small-size negative type, pre-freeze the negative type in the environment of -10°C ± 0.5°C for 12h ± 0.5h, and remove the mold to obtain the inner layer blank SD1 of the stent encapsulating deferoxamine ( Figure 6 );
[0063] Second, put the stent inner layer blank SD1 obtained in the first step into a large-size negative ( Figure 4 ), after mixing the small molecule compound OIC-006 and ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com